SI2441466T1
(sl)
*
|
2004-04-13 |
2015-01-30 |
St Vincent's Hospital Sydney Limited Centre For Immunology |
Sredstvo, ki inhibira MIC-1
|
US7598356B2
(en)
|
2004-07-08 |
2009-10-06 |
Board of Regents of the University of Nebraska by and on behalf of the University of Nebraska Medical Center |
Method for purifying a protein of the cystine-knot superfamily
|
DE102005022047A1
(de)
*
|
2005-05-09 |
2006-11-30 |
Dade Behring Marburg Gmbh |
Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung
|
WO2008013454A2
(en)
*
|
2006-07-26 |
2008-01-31 |
Pepscan Systems B.V. |
Immunogenic compounds and protein mimics
|
US7981998B2
(en)
|
2006-12-14 |
2011-07-19 |
Aileron Therapeutics, Inc. |
Bis-sulfhydryl macrocyclization systems
|
JP5656407B2
(ja)
|
2006-12-14 |
2015-01-21 |
エイルロン セラピューティクス,インコーポレイテッド |
ビス−スルフヒドリル大環状化系
|
WO2008095063A1
(en)
|
2007-01-31 |
2008-08-07 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
US7981999B2
(en)
|
2007-02-23 |
2011-07-19 |
Aileron Therapeutics, Inc. |
Triazole macrocycle systems
|
EP2508531B1
(en)
|
2007-03-28 |
2016-10-19 |
President and Fellows of Harvard College |
Stitched polypeptides
|
EP2474613B2
(en)
*
|
2008-02-05 |
2022-02-16 |
BicycleRD Limited |
Methods and compositions
|
WO2009107771A1
(ja)
*
|
2008-02-27 |
2009-09-03 |
国立大学法人大阪大学 |
金-酸化鉄複合ナノ粒子を用いたペプチドの合成方法
|
AU2010204648B2
(en)
|
2009-01-14 |
2016-09-01 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
GB0914110D0
(en)
*
|
2009-08-12 |
2009-09-16 |
Medical Res Council |
Peptide libraries
|
AU2010298338A1
(en)
|
2009-09-22 |
2012-04-12 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
GB201012410D0
(en)
|
2010-07-23 |
2010-09-08 |
Medical Res Council |
Intracellular immunity
|
SI2603600T1
(sl)
|
2010-08-13 |
2019-04-30 |
Aileron Therapeutics, Inc. |
Peptidomimetični makrocikli
|
GB201013980D0
(en)
|
2010-08-20 |
2010-10-06 |
Ecole Polytech |
Bicyclic uPA inhibitors
|
US9539324B2
(en)
|
2010-12-01 |
2017-01-10 |
Alderbio Holdings, Llc |
Methods of preventing inflammation and treating pain using anti-NGF compositions
|
US9783601B2
(en)
|
2010-12-01 |
2017-10-10 |
Alderbio Holdings Llc |
Methods of preventing inflammation and treating pain using anti-NGF compositions
|
US9884909B2
(en)
|
2010-12-01 |
2018-02-06 |
Alderbio Holdings Llc |
Anti-NGF compositions and use thereof
|
US9078878B2
(en)
|
2010-12-01 |
2015-07-14 |
Alderbio Holdings Llc |
Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
|
US9067988B2
(en)
|
2010-12-01 |
2015-06-30 |
Alderbio Holdings Llc |
Methods of preventing or treating pain using anti-NGF antibodies
|
US11214610B2
(en)
|
2010-12-01 |
2022-01-04 |
H. Lundbeck A/S |
High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
|
WO2012083078A2
(en)
|
2010-12-15 |
2012-06-21 |
The Research Foundation Of State University Of New York |
Croos-linked peptides and proteins, methods of making same, and uses thereof
|
JP6157461B2
(ja)
|
2011-06-30 |
2017-07-05 |
ジェンザイム・コーポレーション |
T細胞活性化の阻害剤
|
WO2013026015A1
(en)
|
2011-08-18 |
2013-02-21 |
Dana-Farber Cancer Institute, Inc. |
Muc1 ligand traps for use in treating cancers
|
GB201117428D0
(en)
|
2011-10-07 |
2011-11-23 |
Bicycle Therapeutics Ltd |
Structured polypeptides with sarcosine linkers
|
LT3299377T
(lt)
|
2011-10-07 |
2021-03-25 |
Bicyclerd Limited |
Struktūrizuoto polipeptido specifiškumo moduliavimas
|
AU2012326026B2
(en)
|
2011-10-18 |
2017-04-13 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocyles
|
IN2014MN01384A
(pl)
*
|
2011-12-19 |
2015-04-03 |
Janssen R & D Ireland |
|
GB201202268D0
(en)
|
2012-02-09 |
2012-03-28 |
Medical Res Council |
Intracellular immunity
|
CN112500466B
(zh)
|
2012-02-15 |
2022-05-03 |
艾瑞朗医疗公司 |
拟肽大环化合物
|
WO2013123267A1
(en)
|
2012-02-15 |
2013-08-22 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
WO2013148117A1
(en)
|
2012-03-27 |
2013-10-03 |
Ngm Biopharmaceuticals, Inc. |
Compositions and methods of use for treating metabolic disorders
|
EP2850095B1
(en)
|
2012-05-17 |
2019-10-09 |
RA Pharmaceuticals, Inc. |
Peptide and peptidomimetic inhibitors
|
US9556229B2
(en)
|
2012-05-18 |
2017-01-31 |
The Regents Of The University Of California |
Modification of peptides using a bis(thioether)arylbridge approach
|
AU2013337388B2
(en)
|
2012-11-01 |
2018-08-02 |
Aileron Therapeutics, Inc. |
Disubstituted amino acids and methods of preparation and use thereof
|
JP6134392B2
(ja)
|
2013-01-25 |
2017-05-24 |
サイモン・エルエルシー |
循環している生物学的に活性な可溶性tnfの選択的低減用の組成物およびtnf媒介性疾患を処置する方法
|
WO2014116789A1
(en)
*
|
2013-01-25 |
2014-07-31 |
Thymon, Llc |
Immunogenic and prophylactic compositions, methods of making same, and method for treating and preventing tnf-mediated disease and hiv-1 infection
|
US9161966B2
(en)
|
2013-01-30 |
2015-10-20 |
Ngm Biopharmaceuticals, Inc. |
GDF15 mutein polypeptides
|
KR101993714B1
(ko)
|
2013-01-30 |
2019-06-28 |
엔지엠 바이오파마슈티컬스, 아이엔씨. |
대사 장애를 치료하는데 이용하기 위한 조성물과 방법
|
EP2767549A1
(en)
|
2013-02-19 |
2014-08-20 |
Adienne S.A. |
Anti-CD26 antibodies and uses thereof
|
GB201306623D0
(en)
|
2013-04-11 |
2013-05-29 |
Bicycle Therapeutics Ltd |
Modulation of structured polypeptide specificity
|
US9920096B2
(en)
*
|
2013-06-25 |
2018-03-20 |
Sepia Pesquisa E Desenvolvimento |
Bradykinin receptor modulators and use thereof
|
ES2715379T3
(es)
|
2013-10-28 |
2019-06-04 |
Bicyclerd Ltd |
Novedosos polipéptidos
|
EP3137482A1
(en)
*
|
2014-05-02 |
2017-03-08 |
MorphoSys AG |
Peptide libraries
|
EP3628680B1
(en)
|
2014-06-12 |
2021-09-08 |
RA Pharmaceuticals, Inc. |
Modulation of complement activity
|
MD20170020A2
(ro)
|
2014-07-30 |
2017-07-31 |
Ngm Biopharmaceuticals, Inc. |
Compoziţii şi metode utilizate pentru tratamentul tulburărilor metabolice
|
SG10201902598VA
(en)
|
2014-09-24 |
2019-04-29 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and formulations thereof
|
BR112017005598A2
(pt)
|
2014-09-24 |
2017-12-12 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos e usos dos mesmos
|
CA2965754C
(en)
|
2014-10-29 |
2024-01-02 |
Bicycle Therapeutics Limited |
Bicyclic peptide ligands specific for mt1-mmp
|
CN115043945A
(zh)
|
2014-10-31 |
2022-09-13 |
Ngm生物制药有限公司 |
用于治疗代谢病症的组合物和方法
|
RS62630B9
(sr)
|
2015-01-28 |
2022-04-29 |
Ra Pharmaceuticals Inc |
Modulatori aktivnosti komplementa
|
KR20170129879A
(ko)
|
2015-03-20 |
2017-11-27 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티드모방 거대고리 및 이의 용도
|
WO2017004548A1
(en)
|
2015-07-01 |
2017-01-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
JP7056932B2
(ja)
|
2015-08-25 |
2022-04-19 |
ヒスタイド アクツィエンゲゼルシャフト |
組織形成誘導用化合物及びその使用
|
EP3347372A4
(en)
|
2015-09-10 |
2019-09-04 |
Aileron Therapeutics, Inc. |
PEPTIDOMIMETIC MACROCYCLES AS MODULATORS OF MCL-1
|
TWI799366B
(zh)
|
2015-09-15 |
2023-04-21 |
美商建南德克公司 |
胱胺酸結骨架平臺
|
WO2017046229A1
(en)
*
|
2015-09-17 |
2017-03-23 |
Histide Ag |
Pharmaceutical association of growth factor receptor agonist and adhesion protein inhibitor for converting a neoplastic cell into a non-neoplastic cell and uses thereof
|
CA2998297A1
(en)
*
|
2015-09-17 |
2017-03-23 |
Histide Ag |
Pharmaceutical association for converting a neoplastic cell into a non-neoplastic cell and uses thereof
|
AU2016323408A1
(en)
*
|
2015-09-17 |
2018-04-19 |
Histide Ag |
Pharmaceutical association of growth factor receptor agonist and adhesion protein inhibitor for converting a neoplastic cell into a non-neoplastic cell and uses thereof
|
EP3389692B1
(en)
|
2015-12-16 |
2020-03-04 |
RA Pharmaceuticals, Inc. |
Modulators of complement activity
|
GB201600903D0
(en)
|
2016-01-18 |
2016-03-02 |
Bicycle Therapeutics Ltd |
Peptide derivaties
|
GB201600911D0
(en)
|
2016-01-18 |
2016-03-02 |
Bicycle Therapeutics Ltd |
Stabilized peptide derivatives
|
US10174119B2
(en)
|
2016-03-31 |
2019-01-08 |
Ngm Biopharmaceuticals, Inc. |
Binding proteins and methods of use thereof
|
GB201607827D0
(en)
|
2016-05-04 |
2016-06-15 |
Bicycle Therapeutics Ltd |
Bicyclic peptide-toxin conjugates specific for MT1-MMP
|
GB201618432D0
(en)
*
|
2016-11-01 |
2016-12-14 |
Matn Scient Ltd |
Detection and treatment of demyelinating diseases
|
US10441663B2
(en)
|
2016-11-27 |
2019-10-15 |
Bicyclerd Limited |
Methods for treating cancer
|
BR112019011053A2
(pt)
|
2016-12-07 |
2019-10-15 |
Ra Pharmaceuticals Inc |
moduladores da atividade do complemento
|
CN110506049A
(zh)
|
2016-12-23 |
2019-11-26 |
拜斯科技术开发有限公司 |
用于结合mt1-mmp的肽配体
|
CN110603261A
(zh)
|
2016-12-23 |
2019-12-20 |
拜斯科阿迪有限公司 |
具有新型键结构的肽衍生物
|
US10624968B2
(en)
|
2017-01-06 |
2020-04-21 |
Bicyclerd Limited |
Compounds for treating cancer
|
GB201706477D0
(en)
|
2017-04-24 |
2017-06-07 |
Bicycle Therapeutics Ltd |
Modification of polypeptides
|
US10857196B2
(en)
|
2017-04-27 |
2020-12-08 |
Bicycletx Limited |
Bicyclic peptide ligands and uses thereof
|
CN111032678A
(zh)
|
2017-06-26 |
2020-04-17 |
拜西克尔德有限公司 |
具有可检测部分的双环肽配体和其用途
|
CN111183147A
(zh)
|
2017-08-04 |
2020-05-19 |
拜斯科技术开发有限公司 |
Cd137特异性的双环肽配体
|
US20200291096A1
(en)
|
2017-08-14 |
2020-09-17 |
Bicyclerd Limited |
Bicyclic peptide ligand sting conjugates and uses thereof
|
EP3668550A1
(en)
|
2017-08-14 |
2020-06-24 |
Bicyclerd Limited |
Bicyclic peptide ligand prr-a conjugates and uses thereof
|
TWI825046B
(zh)
|
2017-12-19 |
2023-12-11 |
英商拜西可泰克斯有限公司 |
Epha2特用之雙環胜肽配位基
|
GB201721265D0
(en)
|
2017-12-19 |
2018-01-31 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for EphA2
|
EP3755725A1
(en)
|
2018-02-23 |
2020-12-30 |
BicycleTX Limited |
Multimeric bicyclic peptide ligands
|
CN112236442A
(zh)
|
2018-04-04 |
2021-01-15 |
拜斯科技术开发有限公司 |
异源串联双环肽复合物
|
GB201808835D0
(en)
|
2018-05-30 |
2018-07-11 |
Bicyclerd Ltd |
Ligands and methods of selecting binding targets for such
|
GB201810327D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to IL-17
|
GB201810320D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to CD38
|
GB201810329D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to integrin avB3
|
US11180531B2
(en)
|
2018-06-22 |
2021-11-23 |
Bicycletx Limited |
Bicyclic peptide ligands specific for Nectin-4
|
GB201810316D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicyclerd Ltd |
Peptide ligands for binding to EphA2
|
WO2020084305A1
(en)
|
2018-10-23 |
2020-04-30 |
Bicycletx Limited |
Bicyclic peptide ligands and uses thereof
|
GB201820320D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for FAPalpha
|
US20220024982A1
(en)
|
2018-12-13 |
2022-01-27 |
Bicycletx Limited |
Bicyclic peptide ligands specific for mt1-mmp
|
GB201820316D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for IL-17
|
GB201820295D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for MT1-MMP
|
GB201820325D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for psma
|
EP3897850A1
(en)
|
2018-12-21 |
2021-10-27 |
Bicyclerd Limited |
Bicyclic peptide ligands specific for pd-l1
|
GB201900526D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for caix
|
GB201900530D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for CD38
|
GB201900528D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for integrin AVB3
|
WO2020165600A1
(en)
|
2019-02-14 |
2020-08-20 |
Bicycletx Limited |
Bicyclic peptide ligand sting conjugates and uses thereof
|
EP3935069A1
(en)
|
2019-03-04 |
2022-01-12 |
Bicyclerd Limited |
Synthesis of bicycle toxin conjugates, and intermediates thereof
|
TW202110485A
(zh)
|
2019-07-30 |
2021-03-16 |
英商拜西可泰克斯有限公司 |
異質雙環肽複合物
|
US20220275053A1
(en)
|
2019-08-13 |
2022-09-01 |
Bicycletx Limited |
Modified multimeric bicyclic peptide ligands
|
GB201912320D0
(en)
|
2019-08-28 |
2019-10-09 |
Bicycletx Ltd |
PBP Binding Bicyclic Peptide Ligands
|
GB201914233D0
(en)
|
2019-10-02 |
2019-11-13 |
Bicyclerd Ltd |
Phage cyclisation assay
|
JP2022551607A
(ja)
|
2019-10-03 |
2022-12-12 |
バイスクルテクス・リミテッド |
ヘテロタンデム二環式ペプチド複合体
|
GB201914872D0
(en)
|
2019-10-15 |
2019-11-27 |
Bicycletx Ltd |
Bicyclic peptide ligand drug conjugates
|
GB201918557D0
(en)
|
2019-12-16 |
2020-01-29 |
Bicycle Tx Ltd |
Bicyclic peptide ligands specific for IL-17
|
GB201918559D0
(en)
|
2019-12-16 |
2020-01-29 |
Bicycle Tx Ltd |
Bicyclic peptide ligands specific for IL-17
|
GB201918558D0
(en)
|
2019-12-16 |
2020-01-29 |
Bicycle Tx Ltd |
Bicyclic peptide ligands specific for IL-17
|
CN114787177A
(zh)
|
2019-12-16 |
2022-07-22 |
拜斯科技术开发有限公司 |
Il-17特异性的双环肽配体
|
GB202002705D0
(en)
|
2020-02-26 |
2020-04-08 |
Bicycletx Ltd |
Anti-infective bicyclic peptide conjugates
|
GB202002706D0
(en)
|
2020-02-26 |
2020-04-08 |
Bicycletx Ltd |
Pbp3 binding bicyclic peptide ligands
|
JP2023520714A
(ja)
|
2020-04-06 |
2023-05-18 |
バイスクルテクス・リミテッド |
Tslpに特異的な二環式ペプチドリガンド
|
WO2021220011A1
(en)
|
2020-05-01 |
2021-11-04 |
Bicycletx Limited |
Anti-infective bicyclic peptide conjugates
|
EP4149954A1
(en)
|
2020-05-15 |
2023-03-22 |
BicycleTX Limited |
Anti-infective bicyclic peptide ligands
|
GB202016331D0
(en)
|
2020-10-15 |
2020-12-02 |
Bicyclerd Ltd |
Bicyclic peptide ligand drug conjugates
|
CN117157305A
(zh)
|
2021-01-08 |
2023-12-01 |
拜斯科技术开发有限公司 |
抗感染的双环肽配体
|
US20240083944A1
(en)
|
2021-01-08 |
2024-03-14 |
Bicycle TX Limited |
Anti-infective bicyclic peptide ligands
|
CA3206525A1
(en)
|
2021-01-08 |
2022-07-14 |
Bicycletx Limited |
Anti-infective bicyclic peptide ligands
|
WO2022148968A1
(en)
|
2021-01-08 |
2022-07-14 |
Bicycletx Limited |
Anti-infective bicyclic peptide ligands
|
WO2022148970A1
(en)
|
2021-01-08 |
2022-07-14 |
Bicycletx Limited |
Anti-infective bicyclic peptide ligands
|
AU2022206577A1
(en)
|
2021-01-08 |
2023-08-24 |
Bicycletx Limited |
Heterotandem bicyclic peptide complexes
|
JP2024502189A
(ja)
|
2021-01-11 |
2024-01-17 |
バイシクルティーエクス・リミテッド |
癌を処置する方法
|
CA3229976A1
(en)
|
2021-09-03 |
2023-03-09 |
Bicycletx Limited |
Synthesis of bicycle toxin conjugates, and intermediates thereof
|
GB202114279D0
(en)
|
2021-10-06 |
2021-11-17 |
Bicycletx Ltd |
Bicyclic peptide ligand drug conjugates
|
GB202114282D0
(en)
|
2021-10-06 |
2021-11-17 |
Bicyclerd Ltd |
Bicyclic peptide ligand drug conjugates
|
GB202116266D0
(en)
|
2021-11-11 |
2021-12-29 |
Bicycletx Ltd |
Novel use
|
WO2023139292A1
(en)
|
2022-01-24 |
2023-07-27 |
Cambridge Enterprise Limited |
Tau therapy
|
WO2024009108A1
(en)
|
2022-07-07 |
2024-01-11 |
Bicycletx Limited |
Anti-infective bicyclic peptide ligands
|